• menu
    Market Place Market Place
    Sourcing support Sourcing Support
    API / FDF
    Excipients
    Services
    Developments
    News
    Market Intel
    #Phispers
    #SpeakPharma
    #LearnMore

    NEWS

    DRUGS & DEVELOPMENTS

    MARKET INTEL by PharmaCompass

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.
    All News #Library

    Daiichi Sankyo`s Vanflyta Approved in Canada

    HEALTH CANADA

    Daiichi Sankyo`s Datroway Receives Approval in Europe

    EMA

    Daiichi Sankyo`s Biologic Datroway Receives Approval in US

    FDA

    Daiichi Sankyo`s Enhertu (fam-trastuzumab deruxtecan-nxki) Receives Suppl Approval in the U.S.

    FDA

    Daiichi Sankyo`s Biologic Enhertu (fam-trastuzumab deruxtecan-nxki) Receives Approval in the U.S.

    FDA

    Daiichi Sankyo`s Vanflyta (quizartinib) Receives Approval in Europe

    EMA

    Daiichi`s Biologic Enhertu (Trastuzumab Deruxtecan) Receives Approval in the U.S.

    FDA

    Daiichi`s Biologic Enhertu (Trastuzumab Deruxtecan) Receives Approval in U.S.

    FDA

    Daiichi Sankyo Enhertu (Trastuzumab) Receives Supplemental Approval in the U.S.

    FDA

    Daiichi Sankyo Enhertu (Trastuzumab) Receives Supplemental Approval in the U.S.

    FDA

    Daiichi Sankyo Europe GmbH Nilemdo (Bempedoic acid) Receives Approval In Europe

    EMA

    Daiichi Sankyo Europe GmbH Roteas (edoxaban) Receives Approval In Europe

    EMA

    Daiichi`s Lixiana (Edoxaban) Approved in EU For Stroke

    EMA

    Daiichi`s LIXIANA® (Edoxaban) Approved in the EU for Stroke Prevention in Nonvalvular AF, DVT and PE

    DAIICHI SANKYO

    Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.